Robert Torray’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-10,643
Closed -$1.17M 102
2022
Q2
$1.17M Sell
10,643
-2,701
-20% -$267K 0.22% 82
2022
Q1
$1.39M Buy
13,344
+555
+4% +$57.6K 0.22% 82
2021
Q4
$1.56M Sell
12,789
-4,724
-27% -$524K 0.23% 79
2021
Q3
$2.01M Sell
17,513
-1,043
-6% -$111K 0.31% 66
2021
Q2
$1.8M Sell
18,556
-2,141
-10% -$186K 0.26% 79
2021
Q1
$1.52M Buy
20,697
+3,231
+18% +$240K 0.24% 86
2020
Q4
$1.19M Buy
17,466
+221
+1% +$14.4K 0.2% 91
2020
Q3
$1.01M Buy
17,245
+6
+0% +$316 0.19% 91
2020
Q2
$780K Buy
17,239
+3,170
+23% +$152K 0.15% 94
2020
Q1
$813K Sell
14,069
-2,811
-17% -$192K 0.18% 86
2019
Q4
$1.05M Buy
16,880
+1,746
+12% +$103K 0.18% 83
2019
Q3
$871K Buy
15,134
+21
+0.1% +$1.16K 0.09% 85
2019
Q2
$820K Sell
15,113
-1,691
-10% -$85.8K 0.09% 88
2019
Q1
$791K Buy
16,804
+393
+2% +$21.8K 0.08% 91
2018
Q4
$930K Buy
16,411
+187
+1% +$10.5K 0.11% 80
2018
Q3
$887K Buy
16,224
+2,223
+16% +$127K 0.09% 85
2018
Q2
$820K Buy
14,001
+886
+7% +$52.9K 0.09% 89
2018
Q1
$744K Buy
13,115
+1,223
+10% +$66.5K 0.08% 93
2017
Q4
$586K Buy
+11,892
New +$542K 0.06% 98

Other funds holding AMN

Robert Torray's AMN Position: Q3 2022 in Review

Robert Torray sold out of AMN Healthcare (AMN) in Q3 2022, closing a stake of 10,643 shares — an estimated $1.17M sold.

Robert Torray first reported a position in AMN in Q4 2017 and held it in 19 quarters. The position peaked at $2.01M in Q3 2021. 465 funds tracked by Wall St. Rank hold AMN as of Q3 2022.

  • Robert Torray reported no remaining AMN Healthcare position as of Q3 2022 after selling out during the quarter.
  • Robert Torray sold 10,643 AMN Healthcare shares in Q3 2022, an estimated $1.17M.
  • Robert Torray first reported a position in AMN Healthcare in Q4 2017 and held it in 19 quarters.
  • Robert Torray's AMN Healthcare position peaked at $2.01M in Q3 2021.
  • 465 funds tracked by Wall St. Rank held AMN Healthcare as of Q3 2022.

Based on Torray Investment Partners's 13F filing for Q3 2022, filed 4 Nov 2022.